Christopher King, MD

Associate Medical Director, Advanced Lung Disease and Transplant Program

PFF Center Director

System Director, Respiratory Therapy

Financial relationships

Attribution:
Self
Type of financial relationship:
Consulting Fee
Ineligible company:
United Therapeutics
Topic:
pah
Date added:
04/06/2023
Mitigation strategy:
Attest
Relationship end date:
02/02/2024
Date reviewed:
02/12/2024
Attribution:
Self
Type of financial relationship:
Consulting Fee
Ineligible company:
Merck
Topic:
pah
Date added:
04/06/2023
Mitigation strategy:
Attest
Relationship end date:
02/02/2024
Date reviewed:
02/12/2024
Attribution:
Self
Type of financial relationship:
Consulting Fee
Ineligible company:
Altavant
Topic:
pah
Date added:
04/06/2023
Mitigation strategy:
Attest
Relationship end date:
02/02/2024
Date reviewed:
02/12/2024

Return to 2024 ISHV Cath, Heart and Lung Conferences: Pulmonary Hypertension